Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website
2015 Conference Logo

2015 HSR&D/QUERI National Conference Abstract

3120 — Time-to-Cessation of Postoperative Opioids: A National-Level Analysis of the Veterans Affairs Healthcare System

Mudumbai S, COIN-Palo Alto; Unger-Hu K, COIN-Palo Alto; Oliva E, COIN-Palo Alto; Lewis E, COIN-Palo Alto; Trafton J, COIN-Palo Alto; Mariano ER, VA Palo Alto; Stafford RS, Stanford University; Wagner T, COIN-Palo Alto; Clark D, VA Palo Alto;

Despite widespread use of perioperative opioids, their standards of care remain poorly defined. We hypothesized that preoperative use would better predict time-to-cessation of postoperative use than pain, substance-use disorder, or affective disorder diagnoses.

We examined data for all VA patients who underwent surgery and discharged after stays > = 1 day in fiscal year 2011. We excluded metastatic cancer patients and included patients with > 1 opioid prescription within 90 days of discharge. We based assessment of preoperative use on opioid prescriptions taken within 180 days before admission. We categorized patients' opioid use as: 1) opioid-naïve, 2) tramadol only, 3) short acting(SA) on an acute or intermittent basis ( < = 90 days), 4) short-acting on a chronic basis, ( > 90 days) or 5) any long-acting(LA). We calculated postoperative time-to-opioid-cessation, from Day 1 to Day 365. We defined cessation as 90, consecutive, opioid-free days. We calculated descriptive statistics and developed a Cox regression model with a priori identified predictors including time-dependent covariates for adjunctive, postoperative pharmacotherapeutics . Sensitivity analyses used cessation definitions of 30 or 180 consecutive days.

Our overall sample (n = 64,391) consisted primarily of men 55-65 years old (47.6%), white (79.9%), urban, married, who underwent diverse surgeries and had significant comorbidity burdens (Charlson score 2+ = 38.5%). Many had chronic pain (56.9%) and took adjunctive pain pharmacotherapy (e.g., non-opioid analgesics; 49.7%) following discharge. Approximately 75% ceased postoperative opioids by one year. Although median time-to-cessation was 43 days, greater preoperative levels of opioid were associated with longer times-to-cessation postoperatively. Preoperative use of SA opioids on an acute/ intermittent basis was associated with substantially greater risk than taking no opioids (HR = 0.51; 95% CI = 0.50-0.52,p < 0.001), but had lower risk than taking tramadol only (HR = 0.33; 95% CI = 0.32-0.34,p < 0.001), SA opioids on a chronic basis (HR = 0.11; 95% CI = 0.11-0.12,p < 0.001), or LA opioids (HR = 0.11; 95% CI = 0.10-0.12,p < 0.001).

Preoperative opioid use better predicts extended postoperative use than pain, substance-use or affective disorder diagnoses.

If preoperative opioid status may be a modifiable risk factor for extended opioid use, focus on the preoperative management of surgical patients' opioid status may be necessary.